Aug. 13 at 8:51 PM
$NMTC At NeuroOne, our mission is to develop minimally invasive technologies designed to improve how neurological conditions are diagnosed and treated.
Today, that mission is supported by a growing portfolio that includes FDA-cleared technologies, commercially available products and a pipeline of new applications being developed from our core electrode platform.
Our work spans both diagnostic and therapeutic uses, with the goal of creating technologies that can make neurological procedures more precise, efficient and less invasive.
Through this channel, we will be sharing updates around our technology, commercial progress, pipeline and the milestones shaping our growth.
We look forward to hearing from the investors following our story. Join the conversation, your voice matters.
